Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Asymchem Laboratories, a US-based company, has inked an agreement with Tianjin Economic-Technological Development Area (TEDA) to set up a pharmaceutical project at the location and intends to invest RMB240m in the project, reported China Knowledge quoting sources familiar with the situation.
Subscribe to our email newsletter
According to the agreement, the proposed project will encompass a space of approximately 50,000sqmt and mainly focuses on the production, distribution, and research and development of biomedical products.
Asymchem Laboratories is a research-based contract manufacturer of active pharmaceutical ingredients, intermediates and drug products in the pharmaceutical industry and has plants in the US and China.